Stedrant Technoclinic Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 1.00 M
as on 11-12-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 32.17%
(FY 2022)
- Profit -11.15%
(FY 2022)
- Ebitda 12.15%
(FY 2022)
- Net Worth 11.79%
(FY 2022)
- Total Assets 13.58%
(FY 2022)
About Stedrant Technoclinic
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kadaba Jayasimha, Sudarshan Rao, Seshadri Sudarshan, and Five other members serve as directors at the Company.
- CIN/LLPIN
U74999KA2017PTC100477
- Company No.
100477
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Stedrant Technoclinic Private Limited offer?
Stedrant Technoclinic Private Limited offers a wide range of products and services, including Building Survey & Soil Investigation, Geotechnical Engineering, Material Testing Labs & Services, Material Testing Services.
Who are the key members and board of directors at Stedrant Technoclinic?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kadaba Jayasimha  | Director | 28-Aug-2017 | Current |
| Sudarshan Rao | Director | 28-Aug-2017 | Current |
| Seshadri Sudarshan | Director | 14-Feb-2017 | Current |
| Sunil Sonnad | Director | 28-Aug-2017 | Current |
| Balemarthy Eswar | Director | 28-Aug-2017 | Current |
| Anitha Kasetty | Director | 28-Aug-2017 | Current |
Financial Performance of Stedrant Technoclinic.
Stedrant Technoclinic Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.17% increase. The company also saw a substantial fall in profitability, with a 11.15% decrease in profit. The company's net worth Soared by an impressive increase of 11.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stedrant Technoclinic?
In 2020, Stedrant Technoclinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Stedrant Technoclinic?
Stedrant Technoclinic has a workforce of 124 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stedrant Technoclinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stedrant Technoclinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
